mIRage-HSi combines sub-500 nm O-PTIR chemical imaging with laser-scanning speed, revealing label-free distributions of key ...
Harvard researchers report that unsaturated phospholipids spontaneously form multilamellar, multivesicular liposomes that ...
Researchers used programmable DNA origami nanorods to show that mechanical flexibility can enhance nanoparticle diffusion through mucus, but only when steric confinement rather than surface-driven ...
Post fracture disrupts femoral rollback mechanics, producing symptomatic instability and potentially accelerating polyethylene wear debris–driven inflammation and bone loss, despite <1% incidence.
TMEM63B, a mechanosensitive lipid scramblase, has an autoinhibitory domain in its C-terminal tail that helps keep it inactive ...
Today we published our latest Global AI Diffusion Report. Global AI diffusion continued to climb in the second quarter of 2026. In June, AI usage was 18.8% of the working-age population worldwide, an ...
ABSTRACT: In this conceptual study, the plant absorption pathway of extracellular organic compounds has been explained by applying fundamental notions of organic chemistry. Indeed, as soon as animal ...
In living cells, biochemical reactions are often confined to subregions in the membrane, facilitating local occurrences of specific signals that regulate membrane protrusion, internalization, fusion, ...
Biological membranes of cells and their subunits (organelles) are organized into tiny regions (nanodomains) made up of fats (lipids) and proteins. Those specialized regions carry out important tasks ...
New cholesterol guidelines advise doctors to begin screening and treating people in their 30s, long before the risks of a heart attack and stroke become significantly higher. For the first time, the ...
WASHINGTON and DALLAS, March 13, 2026 — The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the ...
Enlicitide decanoate, an oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; longer-term data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results